Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00250081 · ClinicalTrials.gov registry record · NA
Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy
A NA study, sponsored by Shriners Hospitals for Children.
- Terminated
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT00250081 is a NA study that was terminated before completion, run by Shriners Hospitals for Children. The registered enrollment target is 38 participants.
The verdict
NCT00250081, a NA study, was terminated before completion, sponsored by Shriners Hospitals for Children.
- TERMINATED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Doctors use different treatments for people with Cerebral Palsy. Surgery is one option. Botulinum toxin injections are another option; these are given directly into spastic muscles to weaken them temporarily. Regular ongoing treatment (splinting, stretching and exercises) is another option. The investigators want to find out if surgery works better than Botulinum Toxin (Botox) injections or regular ongoing treatment (therapy), and if the effects of Botulinum Toxin injections last for longer than six months.
Interventions
- PROCEDURE Upper Extremity Tendon transfer
- PROCEDURE Botulinum Toxin injections in Upper Extremity
- PROCEDURE Regularly ongoing therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2005-02 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00250081
The ClinicalTrials.gov registry entry for NCT00250081 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shriners Hospitals for Children, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Upper Extremity Tendon transfer is the first listed.
NCT00250081 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00250081 about?
NCT00250081 is a clinical study titled "Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy". Doctors use different treatments for people with Cerebral Palsy. Surgery is one option. Botulinum toxin injections are another option; these are given directly into spastic muscles to weaken them temporarily. Regular ongoing treatment (splinting, stretching and exercises) is another option. The inve...
What is the current status of trial NCT00250081?
This trial is currently terminated. It is a NA study. The enrollment target is 38 participants. The study started on 2005-02. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00250081?
The interventions under investigation include: Upper Extremity Tendon transfer (PROCEDURE), Botulinum Toxin injections in Upper Extremity (PROCEDURE), Regularly ongoing therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00250081?
This trial is sponsored by Shriners Hospitals for Children, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.